EUVIMEDEUVIMED entdecken
Crossref

Matrix Metalloproteinase-9 Signaling Regulates Colon Barrier Integrity in Models of HIV Infection

Michael Ohene-Nyako, Amanda L Persons, Christopher Forsyth, Ali Keshavarzian, T Celeste Napier iD

Journal of Neuroimmune Pharmacology · 2024

DOI: 10.1007/s11481-024-10158-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroimmune Pharmacology, 2024. Verfasst von Michael Ohene-Nyako und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Rush University Medical Center, 1735 W. Harrison Street Cohn Research Building Suite #424, Chicago, IL, 60612, USA. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, HIV Infections, Colon, Methamphetamine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Chicago Developmental Center for AIDS Research, NIMH NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with human immunodeficiency virus (HIV) increases risk for maladies of the gut barrier, which promotes sustained systemic inflammation even in virally controlled patients. We previously revealed morphological disorganization of colon epithelial barrier proteins in HIV-1 transgenic (Tg) rats. The current study evaluated mechanisms that may underlie gut barrier pathology induced by toxic HIV-1 proteins. Methamphetamine (meth) use is prevalent among HIV-infected individuals, and meth can exaggerate morbidity of HIV infection. Thus, we determined whether meth exposure worsened HIV-associated gut pathology using colon samples from HIV-1 Tg and non-Tg rats that self-administered meth 2 h/day for 21 days. Immunoblotting was conducted for occludin (a gut barrier protein) and matrix metalloproteinase-9 (MMP-9; a proteinase regulator of occludin). Colon levels of occludin were decreased, and MMP-9 levels and activity were increased in HIV-1 Tg rats. A Pearson correlation revealed an inverse relationship between occludin levels and MMP-9 activity. Doses of meth that were self-administered by Tg rats were lower than other rat models. Meth-induced trends in non-Tg rats were not significant, and meth did not exaggerate effects seen in Tg rats. Accordingly, only the HIV-effects on epithelial function were explored further. Transepithelial resistance (TER) across a monolayer of human colon epithelial cells (Caco-2) was used to examine treatments with the HIV-1 toxic protein, Tat, and the ability of pioglitazone, a PPARγ agonist that inhibits MMP-9, to mitigate Tat-induced changes. Exposure to Tat for 24 h decreased TER, which co-occurred with decreases in levels of barrier tight junction proteins (occludin, claudin-1, and zonula occludens-1) and with increases in the level and activity of MMP-9. Pretreatment or post-treatment with pioglitazone respectively prevented and restored Tat-induced impairments of Caco-2 barrier. Thus, while low doses of meth did not alter barrier proteins in the current study, exposure to HIV-1 proteins disrupted the gut barrier, and this action involved a dysregulation of MMP-9.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 9HIV InfectionsColonMethamphetamineRats, TransgenicSignal TransductionOccludinAnimalsRatsMaleHumansDisease Models, AnimalIntestinal MucosaHIV-1Rats, Sprague-Dawley

Stichwörter der Autor:innen

Caco-2 cellsERKHIV-1 transgenic ratNFκBPPARγ

Substanzen

Matrix Metalloproteinase 9MethamphetamineOccludinMmp9 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology, Rush University Medical Center, 1735 W. Harrison Street Cohn Research Building Suite #424, Chicago, IL, 60612, USA.
  • The Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL, USA.
  • Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298-0614, USA.
  • Department of Physician Assistant Studies, Rush University Medical Center, Chicago, IL, USA.
  • Department of Internal Medicine, Section of Gastroenterology, Rush University Medical Center, Chicago, IL, USA.
  • Department of Anatomy & Cell Biology, Rush University Medical Center, Chicago, IL, USA.

ORCID-Profile: T Celeste Napier

Förderung

  • Chicago Developmental Center for AIDS Research
  • NIMH NIH HHS
  • NIAID NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Ohene-Nyako, M., Persons, A. L., Forsyth, C., Keshavarzian, A., & Napier, T. C. (2024). Matrix Metalloproteinase-9 Signaling Regulates Colon Barrier Integrity in Models of HIV Infection. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-024-10158-2

Vancouver

Ohene-Nyako M, Persons AL, Forsyth C, Keshavarzian A, Napier TC. Matrix Metalloproteinase-9 Signaling Regulates Colon Barrier Integrity in Models of HIV Infection. Journal of Neuroimmune Pharmacology. 2024. doi:10.1007/s11481-024-10158-2

BibTeX
@article{OheneNyako2024,
  author = {Ohene-Nyako, Michael and Persons, Amanda L and Forsyth, Christopher and Keshavarzian, Ali and Napier, T Celeste},
  title = {Matrix Metalloproteinase-9 Signaling Regulates Colon Barrier Integrity in Models of HIV Infection},
  journal = {Journal of Neuroimmune Pharmacology},
  year = {2024},
  doi = {10.1007/s11481-024-10158-2}
}
Kostenlos starten →